MoneyWorks4Me

Mercury Laboratories - Quaterly Results

28 May 2024 Evaluate
The sales for the March 2024 quarter moved down to Rs. 173.67 millions as compared to Rs. 194.31 millions during the year-ago period.The Net Profit of the company reported a remarkable increase of 420.44% to Rs. 19.10  millions  from Rs. 3.67 millions in previous same quarter.Operating profit for the quarter ended March 2024 rose to 30.62 millions as compared to 14.70 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 173.67 194.31 -10.62 755.59 753.34 0.30 755.59 753.34 0.30
Other Income 4.11 4.27 -3.75 10.88 17.19 -36.71 10.88 17.19 -36.71
PBIDT 30.62 14.70 108.30 101.20 102.90 -1.65 101.20 102.90 -1.65
Interest 0.97 0.98 -1.02 3.83 3.62 5.80 3.83 3.62 5.80
PBDT 29.65 13.72 116.11 97.37 99.28 -1.92 97.37 99.28 -1.92
Depreciation 7.16 6.19 15.67 28.16 24.83 13.41 28.16 24.83 13.41
PBT 22.49 7.53 198.67 69.21 74.45 -7.04 69.21 74.45 -7.04
TAX 3.39 3.86 -12.18 12.66 18.66 -32.15 12.66 18.66 -32.15
Deferred Tax -0.99 -0.08 1137.50 -6.34 -3.38 87.57 -6.34 -3.38 87.57
PAT 19.10 3.67 420.44 56.55 55.79 1.36 56.55 55.79 1.36
Equity 12.00 12.00 0.00 12.00 12.00 0.00 12.00 12.00 0.00
PBIDTM(%) 17.63 7.57 133.06 13.39 13.66 -1.95 13.39 13.66 -1.95
Peers
Company Name CMP
Sun Pharma. Inds. 1840.90
Dr. Reddys Labs. 1244.20
Cipla 1385.55
Lupin 2080.35
Zydus Lifesciences 1213.75
View more..